The c.1496T>G variant in MYOC is a missense variant predicted to cause substitution of Isoleucine by Serine at amino acid 499 (p.Ile499Ser). The highest minor allele frequency of this variant was in the European (non-Finnish) genetic ancestry group of gnomAD (v4.1.0) = 0.000001695 (2 alleles out of 1,180,016), which met the ≤ 0.0001 threshold set for PM2_Supporting in a genetic ancestry group of at least 10,000 alleles. The REVEL score = 0.798, which was within the 0.773-0.931 range for PP3_Moderate, predicting a damaging effect on MYOC function. The Ile499Ser protein had increased insolubility levels compared to wild type myocilin protein in this study (PMID: 11004290). The assay met the OddsPath threshold for PS3_Supporting (> 2.1) (when combined with PMID: 10545602) indicating that this variant did impact protein function. Only 1 segregation had been reported for juvenile open angle glaucoma (PMID: 11004290), not meeting the ≥ 3 segregations required for PP1. 2 probands with juvenile or primary open angle glaucoma have been reported carrying this variant (PMID: 11004290 and ANZRAG database [E. Souzeau pers. comm.]), which met PS4_Supporting (≥ 2 probands). Another missense variant (c.1495A>T, p.Ile499Phe, Grantham score = 21, ClinVarID: 1686792) in the same codon has been classified as likely pathogenic for juvenile open angle glaucoma by the ClinGen Glaucoma VCEP. The c.1496T>G, p.Ile499Ser variant has a higher Grantham score (= 142) than the previously classified amino acid change, was not predicted to affect splicing as assessed with SpliceAI (≤ 0.2), and met PP3, meeting the conditions for PM5_Supporting to apply. In summary, this variant met the criteria to receive a score of 6 and to be classified as likely pathogenic (likely pathogenic classification range 6 to 9, adapted from PMID: 32720330) for juvenile open angle glaucoma based on the ACMG/AMP criteria met, as specified by the ClinGen Glaucoma VCEP (v2.0.0, 5 Dec 2024): PP3_Moderate, PS3_Supporting, PS4_Supporting, PM2_Supporting, PM5_Supporting